… create the incentives for vaccine developers to produce usable products for these neglected
diseases… Private firms, rather than funding agencies, would pick which research strategies to …

… Drug companies have no incentive to develop these vaccines, however, since victims of
these diseases cannot afford to pay the prices that would permit a company to recoup its sunk …

… proposal to increase R&D incentives for neglected diseases by comparing the advantages
… marketable pharmaceutical product. In this case, researchers will have strong incentives to …

… This research proposes a decision-support framework that intends to assist any … drugs for
a disease that is currently experiencing neglect, with the selection of an appropriate incentive …

… pharmaceuticals rights holders, and serve as the critical incentive for crucial investments in
pharmaceutical research … facto building blocks for prescription drug economics.This truism is …

… pharmaceutical company, 3 nevertheless, the dream of a new drug for tropical diseases …
Unlike traditional calls for more funding for research into neglected diseases, this enquiry is …

… We analysed outcomes of pharmaceutical research and … ), the pharmaceutical industry has
a strong incentive to develop … answer for neglected diseases: a market monopoly incentive is …

… Pharmaceutical research and development is a complex, costly, … studies have been undertaken
of the pharmaceutical R&D … to amend the Orphan Drug Act to include a strong market pull …

… incentives to develop treatments for neglected diseases, nor the inability of the poor to access
already developed but unaffordable drugs … market failures in the medical field. By focusing …

… deter the pharmaceutical industry from conducting research and … While a strong regulatory
framework is necessary to protect … incentives such as tax credits or reductions as provided in …